What's breaking now, across thousands of outlets.
"No single exposure like this is likely, on its own, to meaningfully change an individual child's risk." Don't miss a story, subscribe here.
We haven't written up this one. ScienceAlert has the full story — the link below goes straight to it.
Alzheon, a biotech that has been attempting to treat Alzheimer's with a checkered drug candidate for more than a decade, is plotting a major fundraise.
Exclusive: FoI documents show senior health officials were warned of concerns about assessment tool weeks after it launched Get our breaking news email , free app or daily news podcast People with…
Exclusive: FoI documents show senior health officials were warned of concerns about assessment tool weeks after it launched Get our breaking news email , free app or daily news podcast People with…
Transcenta, headquartered in China and with a pipeline of over ten therapeutic antibody candidates, is a clinical-stage biopharmaceutical company with expertise in biologics discovery, translational…
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause patients to lose insurance.
